These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24223776)

  • 1. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
    Szkandera J; Stotz M; Eisner F; Absenger G; Stojakovic T; Samonigg H; Kornprat P; Schaberl-Moser R; Alzoughbi W; Ress AL; Seggewies FS; Gerger A; Hoefler G; Pichler M
    PLoS One; 2013; 8(11):e78225. PubMed ID: 24223776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
    Troppan K; Deutsch A; Gerger A; Stojakovic T; Beham-Schmid C; Wenzl K; Neumeister P; Pichler M
    Br J Cancer; 2014 Jan; 110(2):369-74. PubMed ID: 24357794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
    Dalpiaz O; Pichler M; Mannweiler S; Martín Hernández JM; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    Br J Cancer; 2014 May; 110(10):2531-6. PubMed ID: 24691424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Tumour Biol; 2016 Jan; 37(1):361-8. PubMed ID: 26219894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.
    Stotz M; Gerger A; Eisner F; Szkandera J; Loibner H; Ress AL; Kornprat P; AlZoughbi W; Seggewies FS; Lackner C; Stojakovic T; Samonigg H; Hoefler G; Pichler M
    Br J Cancer; 2013 Jul; 109(2):416-21. PubMed ID: 23799847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the mechanisms of immune evasion in pancreatic cancer: may it be a systemic inflammation responsible for dismal survival?
    Holub K; Conill C
    Clin Transl Oncol; 2020 Jan; 22(1):81-90. PubMed ID: 31004253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Friesenbichler J; Stojakovic T; Leithner A; Pichler M
    Am J Surg; 2015 Jul; 210(1):111-6. PubMed ID: 25586599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study.
    Grenader T; Nash S; Adams R; Kaplan R; Fisher D; Maughan T; Bridgewater J
    Br J Cancer; 2016 Mar; 114(6):612-5. PubMed ID: 26889974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
    Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
    Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
    Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
    Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
    Langsenlehner T; Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Gerger A; Pichler M
    World J Urol; 2015 Nov; 33(11):1661-7. PubMed ID: 25617235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine.
    Li L; Ai L; Jia L; Zhang L; Lei B; Zhang Q
    BMC Cancer; 2022 Jan; 22(1):29. PubMed ID: 34980025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.
    Lee GW; Park SW; Go SI; Kim HG; Kim MK; Min CK; Kwak JY; Bae SB; Yoon SS; Lee JJ; Kim KH; Nam SH; Mun YC; Kim HJ; Bae SH; Shin HJ; Lee JH; Park JS; Jeong SH; Lee MH; Lee HS; Park KW; Lee WS; Lee SM; Lee JO; Hyun MS; Jo DY; Lim SN; Lee JH; Kim H; Cho DY; Do YR; Kim JA; Park SK; Kim JS; Kim SJ; Yi HG; Moon JH; Choi CW; Kim SH; Kim BS; Park MR; Shim H; Song MK; Kim Y; Kim K
    Acta Haematol; 2018; 140(3):146-156. PubMed ID: 30253397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.
    Du JH; Lu J
    J Clin Lab Anal; 2019 Feb; 33(2):e22684. PubMed ID: 30461064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
    Dirican A; Kucukzeybek BB; Alacacioglu A; Kucukzeybek Y; Erten C; Varol U; Somali I; Demir L; Bayoglu IV; Yildiz Y; Akyol M; Koyuncu B; Coban E; Ulger E; Unay FC; Tarhan MO
    Int J Clin Oncol; 2015 Feb; 20(1):70-81. PubMed ID: 24532163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy.
    Sun Y; Hu J; Wang R; Du X; Zhang X; E J; Zheng S; Zhou Y; Mou R; Li X; Zhang H; Xu Y; Liao Y; Jiang W; Liu L; Wang R; Zhu J; Xie R
    Cancer Med; 2024 Jul; 13(13):e7453. PubMed ID: 38986683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy.
    Templeton AJ; Rodríguez-Lescure Á; Ruíz A; Alba E; Calvo L; Ruíz-Borrego M; Santaballa A; Rodríguez CA; Crespo C; Ramos M; Gracia-Marco JM; Lluch A; Álvarez I; Casas MI; Sánchez-Aragó M; Caballero R; Carrasco E; Amir E; Martin M; Ocaña A;
    Clin Transl Oncol; 2018 Dec; 20(12):1548-1556. PubMed ID: 29766456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.